Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2025-12-27 @ 6:59 AM
Study NCT ID:
NCT04003792
Status:
UNKNOWN
Last Update Posted:
2020-10-20
First Post:
2019-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.
Sponsor:
Rabin Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-27
First Submit QC Date:
None
Study First Post Date:
2019-07-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-16
Last Update Post Date:
2020-10-20
Last Update Post Date Type:
ACTUAL